Literature DB >> 24761710

Methylprednisolone-induced liver injury: a diagnostic challenge.

Bernardo Melamud, Yoav Lurie, Eran Goldin, Izhar Levi, Yaacov Esayag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24761710

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  9 in total

Review 1.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

2.  Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.

Authors:  Miguel Eugenio Zoubek; José Pinazo-Bandera; Aida Ortega-Alonso; Nelia Hernández; Javier Crespo; Fernando Contreras; Inmaculada Medina-Cáliz; Judith Sanabria-Cabrera; Rocío Sanjuan-Jiménez; Andrés González-Jiménez; Miren García-Cortés; M Isabel Lucena; Raúl J Andrade; Mercedes Robles-Díaz
Journal:  United European Gastroenterol J       Date:  2019-03-24       Impact factor: 4.623

3.  Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis.

Authors:  Ana Torres Oliveira; Sandra Lopes; Maria Augusta Cipriano; Carlos Sofia
Journal:  BMJ Case Rep       Date:  2015-07-21

4.  Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.

Authors:  M Riedl; E Kolbe; E Kampmann; I Krämer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-01-10       Impact factor: 4.256

5.  Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Authors:  E Sabini; E Sisti; B Coco; M Leo; I Ionni; F Menconi; M A Profilo; B Mazzi; R Rocchi; F Latrofa; P Vitti; M Brunetto; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256

6.  Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy.

Authors:  Piotr Miśkiewicz; Anna Jankowska; Kinga Brodzińska; Justyna Milczarek-Banach; Urszula Ambroziak
Journal:  Int J Endocrinol       Date:  2018-10-21       Impact factor: 3.257

7.  Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy.

Authors:  Mohammad Taher Rajabi; Seyed Mohsen Rafizadeh; Abbas Mohammadi; Bahram Eshraghi; Nader Mohammadi; Seyedeh Simindokht Hosseini; Mohammad Bagher Rajabi; Mohammad Mohsen Keshmirshekan; Mansoor Shahriari; Seyedeh Zahra Poursayed Lazarjani; Mohammad Mehdi Parandin
Journal:  Front Med (Lausanne)       Date:  2022-02-11

8.  Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Ko Watanabe; Jun Nakamura; Hitomi Kikuchi; Yuichi Waragai; Hiroyuki Asama; Mika Takasumi; Takuto Hikichi; Hiroshi Watanabe; Katsutoshi Obara; Hiromasa Ohira
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.

Authors:  Viviana Nociti; Marco Biolato; Chiara De Fino; Assunta Bianco; Francesco Antonio Losavio; Matteo Lucchini; Giuseppe Marrone; Antonio Grieco; Massimiliano Mirabella
Journal:  Brain Behav       Date:  2018-05-04       Impact factor: 2.708
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.